Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer

Summary

The goal of this clinical trial is to compare the efficacy and safety of trilaciclib versus placebo in subjects with limited stage small cell lung cancer. The main question it aims to answer is: Does trilaciclib have a myeloprotective effect in subject with limited stage small cell lung cancer? Participants will be randomised to receive either trilaciclib or placebo.

Eligibility

Inclusion Criteria:

* Confirmed diagnosis of Limited-Stage Small Cell Lung Cancer
* Complete recovery from prior anti-tumor surgical procedures
* Measurable and evaluable disease through tumor assessment
* Willingness to participate and sign informed consent form

Exclusion Criteria:

* Extensive Stage Small Cell Lung Cancer
* Active cardiovascular disease
* Known hypersensitivity to trilaciclib, etoposide, carboplatin, cisplatin or any component in their formulations
* Pregnant or nursing women

Conditions3

Interventions2

Locations1 site

Find trials near these locations

Related trials

• Study of Sivelestat Sodium in OPCABG — Affiliated Hospital of Nantong University
• Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin — Shanghai Chest Hospital
• Trilaciclib Combined With Anti-PD-1 Antibody and Chemotherapy in the Treatment of Locally Advanced TNBC — QIAO LI
• Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma — Peking University People's Hospital
• Trilaciclib Prevents Myelosuppression With Chemoradiotherapy — Cancer Institute and Hospital, Chinese Academy of Medical Sciences
• Trilaciclib in Patients With Early-Stage HR-negative Breast Cancer Receiving Adjuvant Chemotherapy — wang shusen
• Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan — Pharmacosmos A/S
• Study of Trilaciclib and Lurbinectidin — UNC Lineberger Comprehensive Cancer Center

Browse More Trials